(Q41513702)

2 October 2017

Neuroendocrine correlates of chronic fatigue syndrome: a brief review (English)

1 reference

2 October 2017

chronic fatigue syndrome

1 reference

Demitrack MA

1

1 reference

2 October 2017

1 January 1997

1 reference

Journal of Psychiatric Research

2 October 2017

1 reference

2 October 2017

31

1 reference

2 October 2017

1

1 reference

2 October 2017

69-82

1 reference

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Hypothalamic dysfunction in overtrained athletes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Serum neopterin and interleukin-6 levels in chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Interleukin-2 and the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Predictors of chronic "postviral" fatigue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Chronic Mononucleosis Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Chronic fatigue. A prospective clinical and virologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

A Comprehensive Immunological Analysis in Chronic Fatigue Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

The psychiatric status of patients with the chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Chronic fatigue syndrome: a working case definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Natural Killer Cells and the Post Viral Fatigue Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Immune function in chronic active Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Chronic fatigue syndrome: clinical condition associated with immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Depression among patients with a chief complaint of chronic fatigue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

AN OUTBREAK of encephalomyelitis in the Royal Free Hospital Group, London, in 1955

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Adrenocortical activity and some clinical findings in acute and chronic fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Follow up of patients presenting with fatigue to an infectious diseases clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Circulating lymphokine levels in the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Lymphocyte phenotype and function in the chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Corticotropin releasing factor produces behavioural activation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Longitudinal study of outcome of chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

Immunologic abnormalities in chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Serologic and Virologic Epidemiology of Epstein-Barr Virus: Relevance to Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900059-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(96)00059-3

1 reference

2 October 2017

1 reference

PubMed ID

9201649